Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A monoclonal antibody to PCSK9 was studied in two single-dose trials in healthy volunteers and one multiple-dose trial in patients with familial or nonfamilial hypercholesterolemia. In all three groups, the antibody reduced levels of LDL cholesterol.
In 2003, Abifadel and colleagues
1
described two families with autosomal dominant hypercho...
Alternative Titles
Full title
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_940835703
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_940835703
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1105803
